Pulmonx Corporation (LUNG) Business Metric Overview - Stocknear

Pulmonx Corporation

NASDAQ: LUNG · Real-Time Price · USD
1.74
0.00 (0.00%)
At close: Sep 05, 2025, 3:59 PM
1.74
0.00%
After-hours: Sep 05, 2025, 04:42 PM EDT

Revenue by Geography

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Asia Pacific Revenue 2.79M 1.66M 1.28M 802K 698K 821K 814K 792K 596K 786K 637K 724K 719K 872K 756K 875K 911K 841K 827K
Asia Pacific Revenue Growth +68.17% +30.15% +59.23% +14.90% -14.98% +0.86% +2.78% +32.89% -24.17% +23.39% -12.02% +0.70% -17.55% +15.34% -13.60% -3.95% +8.32% +1.69% n/a
Emea Revenue 5.48M 6.12M 5.13M 5.96M 5.12M 4.64M 4.85M 5.31M 4.53M 5.13M 4.41M 4.57M 4.05M 5.48M 5.61M 4.75M 4.04M 4.11M 4.44M
Emea Revenue Growth -10.44% +19.38% -13.96% +16.52% +10.23% -4.35% -8.66% +17.24% -11.61% +16.37% -3.61% +12.76% -26.07% -2.25% +18.09% +17.43% -1.49% -7.55% n/a
Other International Geographical Areas Revenue 38K 101K 145K 139K 171K 96K 164K 68K 71K 57K 58K 40K 6.01M 79K 37K 12K n/a 10K n/a
Other International Geographical Areas Revenue Growth -62.38% -30.34% +4.32% -18.71% +78.12% -41.46% +141.18% -4.23% +24.56% -1.72% +45.00% -99.33% +7511.39% +113.51% +208.33% n/a -100.00% n/a n/a
United States Revenue 14.22M 15.88M 13.84M 13.88M 12.87M 13.72M 11.84M 11.02M 9.34M 9.46M 8.4M 8.62M n/a 7.28M 6.86M 6.57M 4.29M 4.87M 5.34M
United States Revenue Growth -10.44% +14.77% -0.32% +7.86% -6.20% +15.90% +7.40% +18.05% -1.26% +12.54% -2.48% n/a n/a +6.05% +4.46% +53.11% -12.00% -8.81% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue 26.7M 26.15M 27.11M 25.41M 25.31M 24.3M 24.32M 23.98M 23.46M 22.74M 21.91M 19.72M 21.23M 20.25M 18.91M 16.69M 17.62M 15.6M 13.96M 10.81M 11.11M 10.19M 10.02M 8.62M 8.36M 7.78M
Selling, General, and Administrative Revenue Growth +2.11% -3.53% +6.67% +0.38% +4.16% -0.08% +1.41% +2.22% +3.20% +3.78% +11.11% -7.15% +4.89% +7.07% +13.32% -5.30% +12.92% +11.78% +29.10% -2.69% +9.06% +1.65% +16.27% +3.16% +7.43% n/a
Research and Development Revenue 5.31M 4.76M 5.72M 3.74M 3.9M 4.21M 3.9M 4.22M 5.71M 4.25M 3.9M 4.37M 3.59M 3.53M 3.71M 2.81M 3.51M 3.03M 2.47M 2M 1.43M 1.56M 1.6M 1.4M 1.45M 1.52M
Research and Development Revenue Growth +11.56% -16.82% +52.72% -3.95% -7.41% +8.06% -7.68% -26.09% +34.26% +8.97% -10.60% +21.48% +1.70% -4.69% +31.72% -19.71% +15.56% +22.73% +23.79% +40.04% -8.88% -2.37% +14.58% -3.65% -4.69% n/a